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Abstract
Introduction:  There  is  a  strong  association  between  vertigo  and  migraine.  Vestibular  migraine
(VM) was  described  in  1999,  and  diagnostic  criteria  were  proposed  in  2001  and  revised  in  2012.
Objective:  To  compare  the  diagnostic  criteria  for  VM  proposed  in  2001  with  2012  criteria  with
respect to  their  diagnostic  power  and  therapeutic  effect  of  VM  prophylaxis.
Methods:  Clinical  chart  review  of  patients  attended  to  in  a  VM  clinic.
Results: The  2012  criteria  made  the  diagnosis  more  speciﬁc,  restricting  the  diagnosis  of  VM  to
a smaller  number  of  patients,  such  that  87.7%  of  patients  met  2001  criteria  and  77.8%  met  2012
criteria.  Prophylaxis  for  VM  was  effective  both  for  patients  diagnosed  by  either  set  of  criteria
and for  those  who  did  not  meet  any  of  the  criteria.
Conclusions:  The  2012  diagnostic  criteria  for  VM  limited  the  diagnosis  of  the  disease  to  a  smaller
number of  patients,  mainly  because  of  the  type,  intensity,  and  duration  of  dizziness.  Patients
diagnosed  with  migraine  and  associated  dizziness  demonstrated  improvement  after  prophylactic
treatment  of  VM,  even  when  they  did  not  meet  diagnostic  criteria.
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PALAVRAS-CHAVE
Transtornos  de
enxaqueca;
Vertigem;
Tontura;
Diagnóstico
Migrânea  vestibular:  análise  comparativa  entre  critérios  diagnósticos
Resumo
Introduc¸ão:  Há  forte  associac¸ão  entre  vertigem  e  enxaqueca.  A  migrânea  vestibular  (MV)  foi
descrita em  1999  e  critérios  diagnósticos  foram  propostos  em  2001  e  revisados  em  2012.
Objetivo:  Comparar  os  critérios  diagnósticos  para  MV  propostos  em  2001  com  os  de  2012,
através de  seu  poder  diagnóstico  e  efeito  terapêutico  da  proﬁlaxia  da  MV.
Método:  Revisão  de  prontuários  de  pacientes  atendidos  em  uma  clínica  de  MV.
Resultados:  Os  critérios  de  2012  tornaram  o  diagnóstico  mais  especíﬁco,  restringindo  a  MV  a  um
número menor  de  pacientes,  sendo  que  87,7%  dos  pacientes  preencheram  os  critérios  de  2001  e
77,8% preencheram  os  critérios  de  2012.  O  tratamento  proﬁlático  para  MV  foi  eﬁcaz  tanto  para
pacientes  diagnosticados  por  algum  dos  critérios  quanto  para  aqueles  que  não  se  enquadravam
em qualquer  critério.
Conclusões:  Os  critérios  diagnósticos  de  2012  para  MV  restringiram  o  diagnóstico  da  doenc¸a  para
um menor  número  de  pacientes,  principalmente  por  causa  do  tipo  de  tontura,  a  sua  intensidade
e durac¸ão.  Pacientes  com  enxaqueca  diagnosticada  e  tontura  associada  apresentaram  melhora
após o  tratamento  proﬁlático  da  MV  mesmo  quando  não  preenchem  critérios  diagnósticos.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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izziness  is  one  of  the  most  common  complaints  in  medi-
al  practice,  especially  in  the  geriatric  age  group,  with  an
ncidence  of  up  to  30%  per  year.1 Despite  the  clinical  pre-
entation,  which  often  manifests  itself  vaguely,  and  the  fact
hat  many  doctors  still  feel  insecure  in  the  management  of
atients  with  dizziness,  it  is  possible  to  reach  an  accurate
iagnosis  in  most  cases.2
Vestibular  disorders  are  the  most  prevalent  causes  of
izziness.  Among  them,  the  most  common  are,  in  descen-
ing  order,  benign  paroxysmal  positional  vertigo  (BPPV),
ndolymphatic  hydrops,  and  vestibular  migraine  (VM).  This
atter  condition  represents  more  than  11%  of  the  causes
f  vestibular  diseases,  present  in  about  1%  of  the  general
opulation.2,3
Migraine  is  a  multifactorial  chronic  disease,  common  in
enetically  susceptible  individuals,4 and  characterized  by  a
hrobbing  unilateral  headache  associated  with  photophobia,
honophobia,  nausea,  and  vomiting.5 VM  can  be  a  disabling
llness  that  affects  about  18%  of  women  and  6%  of  men,5
oursing  with  otoneurological  symptoms  such  as  vertigo,
earing  loss,  tinnitus,  and  aural  fullness;  during  a  crisis,
any  patients  exhibit  these  symptoms  in  the  absence  of
eadache.5
The  association  between  migraine  and  dizziness  has  been
nown  for  a  long  time  and  occurs  three  times  more  often
han  if  it  was  caused  only  by  chance.6 VM  as  a particu-
ar  entity,  however,  was  only  recently  described  (in  1999)
y  Dieterich  and  Brandt,7 characterized  by  vertigo  and
igraine  attacks.  To  date,  its  deﬁnition  is  not  uniform  among
uthors.  Diagnostic  criteria  (Table  1)  were  proposed  by
euhauser  in  20018 and  revised  in  2012  by  the  Bárány  Soci-
ty  and  the  International  Headache  Society  (IHD),3 and  were
ncluded  in  the  third  version  of  the  International  Classiﬁca-
ion  of  Headache  Disorders  (ICHD-3).9
A
T
a
oThe  treatment  of  VM  involves  two  situations10:
.  Crisis  of  migraine-associated  vertigo:  for  the  treatment
of  dizziness  spells,  recommended  drugs  are  the  same
used  for  other  acute  attacks  of  vertigo:  meclizine  or
dimenhydrinate,  for  example.
.  Intercrisis  period:  prophylactic  drugs  are  used.  The  indi-
cation  for  prophylaxis  is  the  intensity  or  frequency  of
symptoms,  or  even  the  patient’s  will.  To  date,  drugs
used  for  this  purpose  are  the  same  used  for  non-dizziness
migraine  prophylaxis:  beta-blockers,  antidepressants,
and  anticonvulsants.  The  choice  of  drug  is  based  on
the  patient’s  proﬁle:  hypertensive  patients  can  use
beta-blockers;  anxious  and  depressive  patients  can  use
antidepressants,  especially  tricyclic  depressants  and
venlafaxine;  patients  without  comorbidities  may  receive
anticonvulsants,  especially  topiramate  and  sodium  val-
proate.
bjective
he  aim  of  this  study  was  to  compare  the  diagnostic  criteria
or  VM  proposed  by  Neuhauser  in  2001  against  the  crite-
ia  reviewed  by  the  Bárány  Society  and  the  International
eadache  Society  in  2012,  with  an  evaluation  of  the  diag-
ostic  power  and  the  therapeutic  effect  of  VM  prophylaxis
n  patients  seen  at  Vestibular  Migraine  Outpatient  Clinic,
niversidade  Federal  de  São  Paulo  (UNIFESP).
ethods cross-sectional  historical  cohort  study  was  conducted.
he  authors  evaluated  clinical  records  of  all  patients
ttended  to  at  the  VM  outpatient  clinic  (Discipline  of  Otol-
gy  and  Neurotology,  Department  of  Otorhinolaryngology
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Table  1  Diagnostic  criteria  for  vestibular  migraine  proposed  by  (1)  Neuhauser,  20018 and  (2)  the  Bárány  Society  and  the  third
International Classiﬁcation  of  Headache  Disorders  (ICHD-3),  2012.3,9
1.  Neuhauser,  2001  2.  Bárány  Society  and  ICHD-3,  2012
Vestibular  migraine,  deﬁned  Vestibular  migraine
A. Vestibular  symptoms  at  least  of  moderate  intensity  A.  At  least  ﬁve  episodes  with  vestibular  symptoms  of  moderate
or severe  intensity,  lasting  from  5  min  to  72  h
B. Current  or  past  history  of  migraine,  according  to
International  Headache  Society  criteria
B.  Current  or  past  history  of  migraine  with  or  without  aura,
according  to  International  Headache  Society  criteria
C. One  of  the  following  migraine  symptoms  during  at
least two  attacks  of  vertigo:  migraine,  photophobia,
phonophobia,  visual  or  other  auras
C.  One  or  more  of  migraine  symptoms  in  at  least  50%  of
vestibular  episodes:
- headache  with  at  least  two  of  the  following  features:
unilateral  location,  pulsating  quality,  intensity  of  pain
(moderate  to  severe),  worsened  by  physical  activity
- photophobia  and  phonophobia
- visual  aura
D. Other  causes  ruled  out  by  an  appropriate  research D.  Cannot  be  better  accounted  for  by  another
vestibular  disease  or  a  diagnosis  of  the  ICHD-3Comment:
Vestibular  symptoms  include  spinning  dizziness  or
another  movement  or  position  illusion.  They  may  be
spontaneous  or  positional.  Vestibular  symptoms  are
‘‘moderate’’  if  they  interfere,  but  do  not  prevent,
daily  activities,  and  ‘‘marked’’  if  the  patient  is
unable  to  carry  out  his/her  daily  activities
Probable  vestibular  migraine  Probable  vestibular  migraine
A. Vestibular  symptoms  of  at  least  moderate  intensity  A.  At  least  ﬁve  episodes  with  vestibular  symptoms  of  moderate
or severe  intensity  lasting  from  5  min  to  72  h
B. One  of  the  following:  (a)  Current  or  past  history  of
migraine  according  to  2004  criteria  of  the
International  Headache  Society;  (b)  migraine
symptoms  during  vestibular  symptoms;  (c)  migraine
precipitants  of  vertigo  in  more  than  50%  of  attacks:
food  triggers,  sleep  problems,  hormonal  changes;  and
(d) response  to  anti-migraine  drugs  in  more  than  50%
of attacks
B.  Only  one  of  the  criteria  B  and  C  for  vestibular  migraine  is
fulﬁlled  (history  of  migraine  or  migraine  symptoms  during  the
episode)
C. Other  causes  ruled  out  by  appropriate  research  C.  Cannot  be  better  accounted  for  by  another  vestibular
di
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phylactic  treatment  with  different  drugs.  The  estimated
treatment  time  ranged  from  three  to  six  months.  Clinical
improvement  was  determined  by  the  difference  between
these  scores,  termed  ‘‘gain.’’
Table  2  Classiﬁcation  of  patients  using  the  2001  and  2012
criteria  for  vestibular  migraine  (VM)  diagnosis.
Groups  Classiﬁcation
A  All  patients
B VM  by  2001  criteriaand  Head  and  Neck  Surgery,  UNIFESP)  since  its  inception
from  2011  until  June  2013.  This  study  was  approved  by
the  Research  Ethics  Committee  of  UNIFESP,  under  code
19615313.13.5.0000.5505.
All  clinical  records  of  patients  with  VM  were  included,
and  the  following  information  was  taken  into  account:
•  Epidemiological  data:  name,  gender,  age,  profession,  and
place  of  birth;
•  Clinical  features  of  the  disease;
•  Past  medical  history;
• Results  of  treatments  evaluated  by  a  visual  analogue  scale
(VAS).
The  medical  records  of  patients  with  other  disorders
causing  dizziness  and/or  headache  and  those  with  illegible
records  or  with  incomplete  or  divergent  information  were
excluded.
The  information  obtained  allowed  for  classiﬁcation  of
patients  according  to  the  diagnostic  criteria  proposed  insease  or  a  diagnosis  of  the  ICHD-3
001  and  2012.  According  to  these  criteria,  patients  were
lassiﬁed  as  having  deﬁnitive  or  probable  VM.
Patients  were  classiﬁed  into  subgroups  to  assess  their
mprovement  in  symptoms  (Table  2).  A  VAS  was  used  for
eadache  and  dizziness.  Each  patient  was  evaluated  by  VAS
n  the  pre-prophylaxis  period  and  again  by  VAS  after  pro-C VM  by  2012  criteria
D Did  not  meet  2001  criteria
E Did  not  meet  2012  criteria
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Table  3  Distribution  of  vestibular  migraine  outpatients  according  to  former  and  current  diagnostic  criteria.
Criteria  2001  2012  p-value
n  %  n  %
Present  71  87.7%  63  77.8%  0.096
Absent 10  12.3%  18  22.2%
p-value <0.001  <0.001
Table  4  Distribution  of  drugs  used  for  vestibular  migraine  prophylaxis  according  to  the  group.
Group  Amitriptyline  Nortriptyline  Fluoxetine  Venlafaxine  Topiramate  Valproate  Flunarizine  Propranolol
A  22  (27.2%)  2  (2.5%)  3  (3.7%)  4  (4.9%)  18  (22.2%)  7  (8.6%)  13  (16.0%)  12  (14.8%)
B 19  (26.7%)  1  (1.4%)  2  (2.8%)  3  (4.2%)  17  (23.9%)  6  (8.5%)  13  (18.3%)  10  (14.1%)
C 17  (26.9%) 1  (1.6%) 2  (3.2%) 2  (3.2%)  13  (20.6%)  5  (7.9%)  13  (20.6%)  10  (15.8%)
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iD 4  (40%) 1  (10%) 1  (10%) 1  (10
E 7  (38.9%)  1  (5.6%)  1  (5.6%)  2  (11
The  results  were  statistically  analyzed,  and  Student’s
 and  ANOVA  tests  were  performed  for  quantitative
ariables.  The  signiﬁcance  level  of  5%  was  adopted;
herefore,  values  of  p  ≤  0.05  were  considered  statistically
igniﬁcant.
esults
inety-four  clinical  records  from  the  VM  outpatient  clinic
ere  analyzed,  of  which  81  were  eligible.  Thirteen  clinical
ecords  without  the  information  sought  or  presenting  incon-
istencies  were  excluded.  Of  the  81  patients,  76  (93.8%)
ere  female.  The  average  age  was  46  years.
Among  the  81  patients,  67  (82.7%)  fully  met  the  diag-
ostic  criteria  proposed  in  2001  for  deﬁnitive  VM  and  four
d
t
e
Table  5  Mean  scores  of  the  visual  analogue  scale  for  headache  b
VAS  for  headache  Mean  
Group  A
Pre  7.70  
Post 3.33  
Group B
Pre  7.78  
Post 3.26  
Group C
Pre  7.80  
Post 3.41  
Group D
Pre  7.00  
Post 4.00  
Group E
Pre  7.27  
Post 3.00  
SD, standard deviation; CI, conﬁdence interval; Group A, all patients; 
migraine; Group C, patients who met one of the 2012 criteria vestibular
Group E, patients who did not meet any of the new criteria.1  (10%)  0  0  2  (20%)
4  (22.2%)  1  (5.6%)  0  2  (11.1%)
4.9%)  for  probable  VM.  Thus,  71  of  the  81  patients  (87.7%)
et  one  of  the  two  criteria  (Table  3).  The  other  ten  patients
ad  migraine  (according  to  ICHD-3  criteria)3 and  vestibular
ymptoms,  but  did  not  meet  the  diagnostic  criteria  for  VM,
ven  after  ruling  out  other  causes  of  dizziness.
Regarding  2012  criteria,  60  (74.1%)  were  classiﬁed  as
eﬁnitive  VM,  and  three  (3.1%)  as  probable  VM.  Thus,  63
f  the  81  patients  (77.8%)  met  criteria  for  VM  (Table  3).
Of  those  ten  patients  who  did  not  meet  2001  diagnostic
riteria,  four  (40%)  had  non-vertigo  dizziness  (i.e.  with  no
llusion  of  movement  or  position),  and  eight  (80%)  had  mild
izziness.
Of  those  18  patients  who  did  not  meet  2012  diagnos-
ic  criteria,  four  patients  (22%)  had  non-vertigo  dizziness,
ight  patients  (44%)  had  mild  dizziness,  and  13  (72%)  had
y  subgroup  of  patients.
SD  CI  p-value
1.97  0.50 <0.001
2.61  0.66
1.85  0.49 <0.001
2.48  0.66
1.94  0.54 <0.001
2.55  0.71
2.97  2.37 0.111
3.85  3.08
2.15  1.27 0.001
3.00  1.77
Group B, patients who met one of the 2001 criteria for vestibular
 migraine; Group D, patients who did not meet any of old criteria;
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Table  6  Mean  scores  of  the  visual  analogue  scale  for  dizziness  by  subgroup  of  patients.
VAS  for  dizziness  Mean  SD  CI  p-value
Group  A
Pre  6.74  2.29  0.57 <0.001
Post 2.79  2.54  0.63
Group B
Pre  7.09  1.87  0.49 <0.001
Post 2.96  2.60  0.68
Group C
Pre  7.02  1.74  0.48 <0.001
Post 3.02  2.65  0.73
Group D
Pre  3.50  3.39  2.71 0.116
Post 1.17  0.98  0.79
Group E
Pre  5.58  3.70  2.10 0.005
Post 1.83  1.85  1.05
SD, standard deviation; CI, conﬁdence interval; Group A, all patients; Group B, patients who met  one of the 2001 criteria for vestibular
migraine; Group C, patients who met one of the 2012 criteria vestibular migraine; Group D, patients who did not meet any of old criteria;
Group E, patients who did not meet any of the new criteria.
Table  7  Mean  of  gain  for  visual  analogue  scale  scores  for  headache  and  dizziness  by  subgroups  of  patients.
VAS  Mean  SD  CI  p-value
Headache
Group  A  −4.37  3.00  0.76 0.846
Group B  −4.52  2.91  0.77
Group C  −4.39  3.00  0.84
Group D −3.00  3.79  3.04
Group E  −4.27  3.17  1.87
Dizziness
Group A  −3.95  3.27  0.81 0.794
Group B  −4.13  3.28  0.86
Group C  −4.00  3.19  0.88
Group D  −2.33  3.01  2.41
Group E  −3.75  3.74  2.12
SD, standard deviation; CI, conﬁdence interval; Group A, all patients; Group B, patients who met  one of the 2001 criteria for vestibular
bular
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cmigraine; Group C, patients who met one of the 2012 criteria vesti
Group E, patients who did not meet any of the new criteria.
symptoms  of  dizziness  only  for  a  few  seconds.  All  ten
patients  who  did  not  meet  2001  diagnostic  criteria  also  could
not  receive  a  diagnosis  of  VM  according  to  current  criteria
(2012).
The  treatment  given  included  antidepressants,  anti-
convulsants,  calcium  channel  inhibitors,  and  -blockers
(Table  4).  The  medication  was  chosen  considering  the
patient’s  proﬁle,  as  recommended  in  the  literature.
VAS  scores  for  pre-treatment  headache  ranged  from  2  to
10,  with  a  mean  of  7  to  7.8  between  groups.  Conversely,  VAS
scores  for  headache  after  prophylactic  treatment  ranged
from  0  to  9,  with  a  mean  of  3  to  4  between  groups  (Table  5).VAS  scores  for  pretreatment  dizziness  ranged  from  0  to
10,  with  a  mean  of  3.5  to  7.09  between  groups.  VAS  scores
for  dizziness  after  prophylactic  treatment  ranged  from  0  to
8,  with  a  mean  of  1.17  to  3.02  between  groups  (Table  6).
t
w
d migraine; Group D, patients who did not meet any of old criteria;
For  headache,  the  mean  values  of  gain  ranged  from  −3.00
o  −4.52.  For  dizziness,  the  mean  values  of  gain  ranged  from
2.33  to  −4.13.  When  compared  between  groups,  in  nei-
her  case  did  gain  values  for  headaches  and  for  dizziness
emonstrate  a  statistically  signiﬁcant  difference  (Table  7).
iscussion
M  is  a  heterogeneous  condition,  usually  episodic  and  with
arying  symptoms;  however,  this  disease  can  be  chronic,  as
an  migraine  without  dizziness.11 This  is  a  prevalent  condi-
ion  in  women  in  the  third  and  fourth  decades  of  life4;  this
as  also  observed  in  the  results  of  this  study.
This  study  found  a  decrease  in  the  number  of  patients
iagnosed  with  VM  according  to  the  criteria  proposed  in
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012,  in  comparison  with  those  of  2001.  The  diagnostic
riteria  of  2012  were  proposed  by  the  Bárány  Society  in  con-
unction  with  the  International  Headache  Society.  Regarding
his  publication,  it  can  be  observed  that  the  principal
ontroversy  occurred  with  respect  to  the  sensitivity  and
peciﬁcity  of  the  criteria,  considering  that  very  speciﬁc
riteria  would  increase  the  number  of  false-negative  cases;
owever,  very  sensitive  criteria  would  increase  the  number
f  false-positive  cases.3 Considering  this  sample,  it  was  clear
hat  the  new  criteria  are  more  speciﬁc,  because  they  restrict
he  diagnosis  to  a  smaller  number  of  patients.
The  type  of  dizziness  and  its  duration  and  intensity  were
he  main  culprits  for  this  reduction  in  the  number  of  patients
ith  a  diagnosis  of  VM  by  the  new  criteria.  The  diagnostic
riteria  of  2012  restricted  these  characteristics;  with  their
pplication  in  this  series,  eight  of  71  patients  (11.3%)  were
xcluded.  This  has  resulted  in  a  more  speciﬁc,  but  less  sen-
itive,  diagnosis.
Although  diagnosed  with  migraine  by  ICHD-3  criteria,  ten
atients  (12%)  did  not  ﬁt  the  classiﬁcation  of  VM  either
y  2001  or  2012  criteria.  Thus,  these  patients  would  no
onger  receive  an  etiologic  diagnosis.  In  fact,  they  would  be
iagnosed  with  a  vestibular  syndrome  to  be  clariﬁed.  Never-
heless,  these  patients  were  not  excluded  from  this  clinic,
ecause  of  other  diagnostic  tips,  for  example,  a  strong  fam-
ly  history  of  migraine  or  a  history  of  motion  sickness;  and,
n  addition,  they  showed  a  good  therapeutic  response.
Patients  diagnosed  with  VM  by  the  2001,  but  not  by  2012
riteria,  responded  to  drug  therapy  in  a similar  manner  to
atients  in  groups  B  and  C,  with  a  statistically  signiﬁcant
mprovement  seen  in  the  VAS  scale.  This  indicates  the  pos-
ibility  that  these  patients  are  actually  suffering  VM,  and
herefore  would  be  considered  as  false-negative  cases  by
012  diagnostic  criteria.
The  use  of  diagnostic  criteria  for  the  determination
f  diseases  has  great  scientiﬁc  value,  because  this  strat-
gy  standardizes  diagnostics,  mainly  for  scientiﬁc  studies.
owever,  their  value  to  medical  practice  should  be  put  in
erspective,  as  there  are  other,  often  variables  in  the  art
f  establishing  a  diagnosis  that  are  not  quantiﬁable.  In  the
resent  sample,  the  results  of  the  prophylactic  treatment
f  patients  assessed  by  VAS  showed  no  statistically  signiﬁ-
ant  difference  between  post-treatment  scores  of  patients
ho  met  vs.  those  who  did  not  meet  the  diagnostic  crite-
ia.  There  are  two  possible  explanations  for  this  ﬁnding:  the
iagnosis  of  VM  was  correct  --  even  in  cases  that  did  not
t  the  diagnostic  criteria;  or  the  prophylactic  treatment  of
M  improved  the  cases  of  vestibular  disorders  not  resulting
rom  migraine.  However,  no  literature  reports  of  anti-vertigo
1Salmito  MC  et  al.
ffect  for  antidepressant  or  anticonvulsant  drugs  could  be
ound.  Additional  studies  are  needed  so  that  a  more  thor-
ugh  understanding  of  this  problem  is  obtained.
onclusions
he  2012  diagnostic  criteria  for  VM  restrict  the  diagnosis  of
his  disease  to  a  lesser  number  of  patients.  The  key  features
esponsible  for  this  reduction  were  the  type  of  dizziness,  and
ts  intensity  and  duration.
Patients  diagnosed  with  migraine  and  with  complaints  of
n  associated  dizziness  showed  improvement  of  dizziness  (by
AS),  after  drug  prophylaxis  for  VM.
onﬂicts of  interest
he  authors  declare  no  conﬂicts  of  interest.
eferences
1. Lee ATH. Diagnosing the cause of vertigo: a practical approach.
Hong Kong Med J. 2012;18:327--32.
2. Strupp M, Brandt T. Peripheral vestibular disorders. Curr Opin
Neurol. 2013;26:81--9.
3. Lempert T, Olesen J, Furman J, Waterston J, Seemungal B,
Carey J, et al. Vestibular migraine: diagnostic criteria. J Vestib
Res. 2012;22:167--72.
4. Bolay H, Bayazit YA, Gündüz B, Ugur AK, Akc¸ali D, Altunyay S,
et al. Subclinical dysfunction of cochlea and cochlear effer-
ents in migraine: an otoacoustic emission study. Cephalalgia.
2008;28:309--17.
5. Dash AK, Panda N, Khandelwal G, Lal V, Mann SS. Migraine
and audiovestibular dysfunction: is there a correlation? Am J
Otolaryngol. 2008;29:295--9.
6. Jensen R, Stovner LJ. Epidemiology and comorbidity of
headache. Lancet Neurol. 2008;7:354--61.
7. Dieterich M, Brandt T. Episodic vertigo related to migraine (90
cases): vestibular migraine. J Neurol. 1999;246:883--92.
8. Neuhauser H, Leopold M, VonBrevern M, Arnold G, Lempert T.
The interrelations of migraine, vertigo, and migrainous vertigo.
Neurology. 2001;56:436--41.
9. Headache Classiﬁcation Committee of the International
Headache Society (IHS). The International Classiﬁcation of
Headache Disorders, 3rd edition (beta version). Cephalalgia.
2013;33:629808.
0. Bisdorff AR. Management of vestibular migraine. Ther Adv Neu-
rol Disord. 2011;4:183--91.
1. Cohen JM, Bigal ME, Newman LC. Migraine and vestibular
symptoms-identifying clinical features that predict vestibular
migraine. Headache. 2011;51:1393--7.
